FY2025 EPS Estimates for ELDN Cut by Cantor Fitzgerald
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Eledon Pharmaceuticals in a note issued to investors on Monday, March 24th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will earn ($1.23) per share for the year, down from their […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Eledon Pharmaceuticals in a note issued to investors on Monday, March 24th. Cantor Fitzgerald analyst P. Stavropoulos now forecasts that the company will earn ($1.23) per share for the year, down from their […]
